Shi CL - Search Results

1

A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.

Shi CL, Zhang XY, Han BH, He WZ, Shen J, Chu TQ. Shi CL, et al. Med Oncol. 2011 Dec;28(4):1441-6. doi: 10.1007/s12032-010-9632-y. Epub 2010 Jul 27. Med Oncol. 2011. PMID: 20661664

2

[Clinical observation of gefitinib for the treatment of 125 cases with advanced non-small cell lung cancer].

Gu AQ, Wang HM, Shi CL, Xiong LW, Gao ZQ, Han BH. Gu AQ, et al. Among authors: shi cl. Zhonghua Zhong Liu Za Zhi. 2010 Jan;32(1):71-4. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20211075 Clinical Trial. Chinese.

3

[Clinical Observation of Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer: A Report of 92 Eases.].

Gu A, Xiong L, Wang H, Shi C, Gao Z, Han B. Gu A, et al. Zhongguo Fei Ai Za Zhi. 2009 Dec 20;12(12):1305-8. doi: 10.3779/j.issn.1009-3419.2009.12.17. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20723390 Free article. Chinese.

4

The expression of stem cell-related indicators as a prognostic factor in human lung adenocarcinoma.

Zhang XY, Dong QG, Huang JS, Huang AM, Shi CL, Jin B, Sha HF, Feng JX, Geng Q, Zhou J, Xu HL, Han BH. Zhang XY, et al. Among authors: shi cl. J Surg Oncol. 2010 Dec 1;102(7):856-62. doi: 10.1002/jso.21718. J Surg Oncol. 2010. PMID: 20818602

5

[A primary study of immunotherapy with carcinoembryonic antigen peptide-pulsed, autologous human cultured dendritic cells in patients with advanced non-small cell lung cancer].

Han B, Zhong H, Fan X, Feng G, Li R, Gong L, Chu T, Zhang W, Jin B, Shi C, Zhao Y, Sha H, Dong Q, Liao M. Han B, et al. Zhongguo Fei Ai Za Zhi. 2006;9(4):340-4. doi: 10.3779/j.issn.1009-3419.2006.04.09. Zhongguo Fei Ai Za Zhi. 2006. PMID: 21176451 Free article. Chinese.

6

[Role of erlotinib 100 mg/d in the treatment of advanced adenocarcinoma lung cancer failed to previous chemotherapy].

Shi C, Han B, Gu A, Xiong L, Shen J. Shi C, et al. Zhongguo Fei Ai Za Zhi. 2011 Jun;14(6):529-33. doi: 10.3779/j.issn.1009-3419.2011.06.09. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21645458 Free PMC article. Clinical Trial. Chinese.

7

[A multicenter, randomized, double-blind, placebo-controlled safety study to evaluate the clinical effects and quality of life of paclitaxel-carboplatin (PC) alone or combined with endostar for advanced non-small cell lung cancer (NSCLC)].

Han BH, Xiu QY, Wang HM, Shen J, Gu AQ, Luo Y, Bai CX, Guo SL, Liu WC, Zhuang ZX, Zhang Y, Zhao YZ, Jiang LY, Shi CL, Jin B, Zhou JY, Jin XQ. Han BH, et al. Among authors: shi cl. Zhonghua Zhong Liu Za Zhi. 2011 Nov;33(11):854-9. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22335953 Clinical Trial. Chinese.

8

Clinical observation of gefitinib as a first-line therapy in sixty-eight patients with advanced NSCLC.

Gao Z, Han B, Wang H, Shi C, Xiong L, Gu A. Gao Z, et al. Oncol Lett. 2012 May;3(5):1064-1068. doi: 10.3892/ol.2012.631. Epub 2012 Mar 5. Oncol Lett. 2012. PMID: 22783392 Free PMC article.

9

ERCC1 protein as a guide for individualized therapy of late-stage advanced non-small cell lung cancer.

Gao Z, Han B, Shen J, Gu A, Qi D, Huang J, Shi C, Xiong L, Zhao Y, Jiang L, Wang H, Chen Y. Gao Z, et al. Exp Ther Med. 2011 Sep;2(5):811-815. doi: 10.3892/etm.2011.276. Epub 2011 May 30. Exp Ther Med. 2011. PMID: 22977580 Free PMC article.

10

Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancer.

Gu A, Shi C, Xiong L, Chu T, Pei J, Han B. Gu A, et al. Chin J Cancer Res. 2013 Feb;25(1):90-4. doi: 10.3978/j.issn.1000-9604.2012.12.07. Chin J Cancer Res. 2013. PMID: 23372346 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters